[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335096-105":59,"doc-detail-335096-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","duodenal-fluid-analysis-as-a-rewarding-approach-to-detect-low-abundance-mutations-in-biliopancreatic-cancers","Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers","","Diagnosis of biliopancreatic cancers by existing serum tumor markers, imaging, and histopathological examination remains challenging. Liquid biopsy potential was evaluated by analyzing circulating cell-free DNA from secretin-stimulated duodenal fluid and matched plasma of 10 patients and 8 controls using AmpliSeq HD with Ion Torrent next-generation sequencing. Median cfDNA concentration was higher in duodenal fluid. Thirteen variants were found overall, with most low-abundance mutations exclusively detected in duodenal fluid, supporting its usefulness for identifying cancer-associated alterations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/duodenal-fluid-analysis-as-a-rewarding-approach-to-detect-low-abundance-mutations-in-biliopancreatic-cancers/335096/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/duodenal-fluid-analysis-as-a-rewarding-approach-to-detect-low-abundance-mutations-in-biliopancreatic-cancers/335096.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are biliopancreatic cancers difficult to diagnose early?","Question",{"text":112,"@type":113},"They are often diagnosed at an advanced stage, and standard serum markers, imaging, and histopathological tissue examination have limited sensitivity and specificity for precursor lesions and for distinguishing malignant from nonmalignant conditions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was duodenal fluid used in this study?",{"text":117,"@type":113},"Secretin-stimulated duodenal fluid and matched plasma were collected, and circulating cell-free DNA was analyzed by AmpliSeq HD with Ion Torrent next-generation sequencing to profile somatic variants.",{"name":119,"@type":110,"acceptedAnswer":120},"What was the key finding about cfDNA and detected mutations?",{"text":121,"@type":113},"Duodenal fluid showed a higher median cfDNA concentration than plasma, and most detected variants—many with low abundance (VAF \u003C 6%)—were exclusively identified in duodenal fluid from patients with biliopancreatic cancers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335096,1790435065,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nDuodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers  \nFrancesca Tavano 1, *, Anna Latiano 1, Orazio Palmieri 1, Domenica Gioffreda 1, Tiziana Latiano 1, Annamaria Gentile 1, Matteo Tardio 2, Tiziana Pia Latiano 3, Marco Gentile 1, Fulvia Terracciano 1 and Francesco Perri 1  \nCitation: Tavano, F.; Latiano, A.; Palmieri, O.; Gioffreda, D.; Latiano, T.; Gentile, A.; Tardio, M.; Latiano, T.P.; Gentile, M.; Terracciano, F.; et al. Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers. Int. J. Mol. Sci. 2024, 25, 8436. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25158436](10.3390/ijms25158436)  \nAcademic Editors: Bram Ramjiawan and Paramjit S. Tappia  \nReceived: 20 June 2024  \nRevised: 25 July 2024  \nAccepted: 30 July 2024  \nPublished: 2 August 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Division of Gastroenterology and Endoscopy, Fondazione IRCCS “Casa Sollievo della Sofferenza” Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy  \n2 Department of Surgery, Fondazione IRCCS “Casa Sollievo della Sofferenza” Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy  \n3 Department of Oncology, Fondazione IRCCS “Casa Sollievo della Sofferenza” Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy  \n* Correspondence: [f.tavano@operapadrepio.it](f.tavano@operapadrepio.it)  \nAbstract: Diagnosis of biliopancreatic cancers by the available serum tumor markers, imaging, and histopathological tissue specimen examination remains a challenge. Circulating cell-free DNA derived from matched pairs of secretin-stimulated duodenal fluid (DF) and plasma from 10 patients with biliopancreatic diseases and 8 control subjects was analyzed using AmpliSeq™ HD technology for Ion Torrent Next-Generation Sequencing to evaluate the potential of liquid biopsy with DFin biliopancreatic cancers. The median cfDNA concentration was greater in DF-derived than in plasma-derived samples. A total of 13 variants were detected: 11 vs. 1 were exclusive for DF relative to the plasma source, and 1 was shared between the two body fluids. According to the four-tier systems, 10 clinical tier-I–II (76.9%), 1 tier–III (7.7%), and 2 tier–IV (15.4%) variants were identified. Notably, the 11 tier-I-III variants were exclusively found in DF-derived cfDNA from five patients with biliopancreatic cancers, and were detected in seven genes (KRAS, TP53, BRAF, CDKN2A, RNF43, GNAS, and PIK3CA); 82% of the tier-I-III variants had a low abundance, with a VAF \u003C 6% . The mutational profiling of DF seems to be a reliable and promising tool for identifying cancer-associated alterations in malignant cancers of the biliopancreatic tract.  \nKeywords: biliopancreatic cancers; liquid biopsy; duodenal fluid; mutation profiling; somatic variants  \n1. Introduction  \nBiliopancreatic cancers, including pancreatic cancer and cholangiocarcinomas (CCAs), are aggressive and are often diagnosed at an advanced stage, resulting in a dismal prognosis. Pancreatic ductal adenocarcinoma (PDAC) is the most prevalent histologic type of pancreatic cancer; PDAC precursors include microscopic lesions represented by pancreatic intraepithelial neoplasia (PanIN) and macroscopic mucinous lesions, namely, intraductal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasm (MCN), both of which are characterized by low or high dysplasia or by the presence of invasive carcinoma [1,2] . CCAs constitute a diverse group of rare malignancies arising in the biliary tract [3]; CCAs are often indistinguishable from PDAC by sta","cbCairLWiIO5gD3d","https://ap.wps.com/l/cbCairLWiIO5gD3d","pdf",2279016,17,"English","# Abstract\n# 1. Introduction","[{\"question\":\"Why are biliopancreatic cancers difficult to diagnose early?\",\"answer\":\"They are often diagnosed at an advanced stage, and standard serum markers, imaging, and histopathological tissue examination have limited sensitivity and specificity for precursor lesions and for distinguishing malignant from nonmalignant conditions.\"},{\"question\":\"How was duodenal fluid used in this study?\",\"answer\":\"Secretin-stimulated duodenal fluid and matched plasma were collected, and circulating cell-free DNA was analyzed by AmpliSeq HD with Ion Torrent next-generation sequencing to profile somatic variants.\"},{\"question\":\"What was the key finding about cfDNA and detected mutations?\",\"answer\":\"Duodenal fluid showed a higher median cfDNA concentration than plasma, and most detected variants—many with low abundance (VAF \\u003c 6%)—were exclusively identified in duodenal fluid from patients with biliopancreatic cancers.\"}]","Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers | PDF",1790009643,43]